References
- Spiro RH : Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg 8 : 177, 1986 https://doi.org/10.1002/hed.2890080309
- Fordice J, Kershaw C, El-Naggar et al : Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125 : 149, 1999
- Airoldi M, Fornari G, Pedani F et al : Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20(5C) : 3781, 2000
- Rusch V : Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3 : 515, 1997
- Khazaie K, Schirrmacher V, Lichtner RB : EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12 : 255, 1993 https://doi.org/10.1007/BF00665957
- Radinsky R, Risin S, Fan D et al : Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1 : 19, 1995
- Kawashima M : Chemoradiotherapy for head and neck cancer: current status and perspectives. Int J Clin Oncol 9 : 421, 2004 https://doi.org/10.1007/s10147-004-0445-x
- Holsinger FC, Doan DD, Jasser SA, et al. Epidermal growth factor receptor blockade potentiates apoptosis mediated by paclitaxel and leads to prolonged survival in a murine model of oral cancer. Clin Cancer Res 9 : 3183-9, 2003
- Esser S, Wolburg K, Wolburg H et al : Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140 : 947, 1998 https://doi.org/10.1083/jcb.140.4.947
- Ferrara N, Houck K, Jakeman L et al : Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 : 18, 1992
- Sauter ER, Nesbit M, Watson JC, et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck. Clin Cancer Res 1999; 5: 775-82
- Yigitbasi OG, Younes MN, Doan D et al : Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 64 : 7977, 2004 https://doi.org/10.1158/0008-5472.CAN-04-1477
- Ang KK, Andratschke NH, Milas L : Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58 : 959, 2004 https://doi.org/10.1016/j.ijrobp.2003.07.010
- Bowden J, Brennan PA, Umar T et al : Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol 29 : 585, 2002 https://doi.org/10.1034/j.1600-0560.2002.291003.x
- Craven RJ, Lightfoot H, Cance WG : A decade of tyrosine kinases: from gene discovery to therapeutics. Surg Oncol 12 : 39, 2003 https://doi.org/10.1016/S0960-7404(03)00004-5
- Barnes CJ, Bagheri-Yarmand R, Mandal M et al : Suppression of epidermal growth factor receptor, mitogenactivated protein kinase, and Pak1 pathway and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Mol Cancer Ther 2 : 345, 2003
- Fidler IJ : Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5 : 29, 1986 https://doi.org/10.1007/BF00049529
- Killion JJ, Radinsky R, Fidler IJ : Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metas Rev 17 : 279, 1999
- Fidler IJ, Wilmanns C, Staroselsky A et al : Modulation of tumor cell reponse to chemotherapy by the organ environment. Cancer Metastasis Rev 13 : 209, 1994 https://doi.org/10.1007/BF00689637
- Dong Z, Radinsky R, Fan D et al : Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon carcinoma cell line. J Natl Cancer Inst 86 : 913, 1994 https://doi.org/10.1093/jnci/86.12.913
- Kubota T : Metastatic models of human cancer xenografted in mice: the importance of orthotopic transplantation. J Cell Biochem 56 : 4, 1994 https://doi.org/10.1002/jcb.240560103
- Fu XY, Theodorescu D, Kerbel RS et al : Extensive multiorgan metastasis following orthotopic implantation of histologically- intact human bladder carcinoma tissue in nude mice. Int J Cancer 49 : 938, 1991 https://doi.org/10.1002/ijc.2910490623
- Spiro RH : Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg 8 : 177, 1986 https://doi.org/10.1002/hed.2890080309
- Herbst RS, Langer CJ : Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol 29 : 27, 2002
- Goldman CK : Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4 : 121, 1993
- Gille J, Swerlick RA, Caughman SW : Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. Embo J 16 : 750, 1997 https://doi.org/10.1093/emboj/16.4.750
- de Jong JS : Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 184 : 53, 1998 https://doi.org/10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7
- Neuchrist C, Quint C, Pammer A et al : Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol 119 : 732, 1999 https://doi.org/10.1080/00016489950180711
- Obermair A, Kohlberger P, Bancher-Todesca D et al : Influence of microvessel density and vascular permeability factor/ vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63 : 204, 1996 https://doi.org/10.1006/gyno.1996.0307
- Vered M, Braunstein E, Buchner A : Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24 : 632, 2002 https://doi.org/10.1002/hed.10104
- Ishibashi H, Shiratuchi T, Nakagawa K et al : Hypoxiainduced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 : 77, 2001 https://doi.org/10.1016/S1368-8375(00)00062-2
- Yu F, Jiang XZ, Chen WT et al : Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland. Shanghai Kou Qiang Yi Xue 12 : 443, 2003
- Baselga J, Rischin D, Ranson M et al : Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol 20 : 4292, 2002 https://doi.org/10.1200/JCO.2002.03.100
- Cohen EE, Rosen F, Stadler WM et al : Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21: 1980, 2003 https://doi.org/10.1200/JCO.2003.10.051
- Koch AE, Polverini PJ, Kunkel SL et al : Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 258 : 1798, 1992 https://doi.org/10.1126/science.1281554
- Chang C, Werb Z : The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biol 11 : S37, 2001
- Luca M, Huang S, Gershenwald JE et al : Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 151 : 41, 1997
- Bergers G, Brekken R, McMahon G et al : Matrix metalloproteinase- 9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 : 737, 2000 https://doi.org/10.1038/35036374